Table 2.
Univariate analysis for survival of ovarian metastases from extragenital cancer
| Patients % | Median OS (m) | 95% CI (m) | P value | |
|---|---|---|---|---|
|
Primary cancer site | ||||
| Colon & Rectum |
49.0 |
8.8 |
6.5-11.2 |
0.036† |
| Stomach |
40.8 |
7.4 |
6.3-8.4 |
|
| Breast |
8.2 |
41.0 |
2.0-85.0 |
0.000‡ |
| Biliary Duct |
1.4 |
6.0 |
|
|
| Liver |
0.7 |
NR |
|
|
|
Timing of metastasis to ovary | ||||
| Metachronous |
62.6 |
10.2 |
8.3-13.2 |
0.027 |
| Synchronous |
37.4 |
8.1 |
6.7-9.4 |
|
|
Combined with metastases outside ovaries | ||||
| No |
72.8 |
10.2 |
8.1-12.4 |
0.001 |
| Yes |
27.2 |
5.9 |
3.8-8.0 |
|
|
Locally invasion | ||||
| No |
70.7 |
13.7 |
6.4-21.0 |
0.007 |
| Yes |
29.3 |
8.0 |
7.1-9.0 |
|
|
Ascites | ||||
| ≥1000 mL |
26.5 |
6.0 |
8.2-11.7 |
0.005 |
| <1000 mL | 73.5 | 9.9 | 3.5-8.5 | |
†P value for colorectal cancer versus gastric cancer; ‡ P value for breast cancer versus gastrointestinal cancer.